A citation-based method for searching scientific literature

B Zambrowicz, J Freiman, P M Brown, K S Frazier, A Turnage, J Bronner, D Ruff, M Shadoan, P Banks, F Mseeh, D B Rawlins, N C Goodwin, R Mabon, B A Harrison, A Wilson, A Sands, D R Powell. Clin. Pharmacol. Ther. 2012
Times Cited: 137



Hassan Rahmoune, Paul W Thompson, Joanna M Ward, Chari D Smith, Guizhu Hong, John Brown. Diabetes 2005
Times Cited: 414




List of shared articles



Times cited

Adjunct therapies in treatment of type 1 diabetes.
Itivrita Goyal, Alamgir Sattar, Megan Johnson, Paresh Dandona. J Diabetes 2020
0

What does sodium-glucose co-transporter 1 inhibition add: Prospects for dual inhibition.
Jessica A Dominguez Rieg, Timo Rieg. Diabetes Obes Metab 2019
5

SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice.
Leonardo Spatola, Silvia Finazzi, Claudio Angelini, Marco Dauriz, Salvatore Badalamenti.  2018
10






SGLT2 inhibitors.
I Dardi, T Kouvatsos, S A Jabbour. Biochem. Pharmacol. 2016
11

Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition.
S P Rajeev, D J Cuthbertson, J P H Wilding. Diabetes Obes Metab 2016
32

Sodium glucose transport modulation in type 2 diabetes and gastric bypass surgery.
Gregory Baud, Violeta Raverdy, Caroline Bonner, Mehdi Daoudi, Robert Caiazzo, Fran├žois Pattou. Surg Obes Relat Dis 2016
7


Sodium glucose cotransporter 2 inhibitors.
John R White. Med. Clin. North Am. 2015
2

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.
Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands. Diab Vasc Dis Res 2015
50

Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside.
Sunder Mudaliar, David Polidori, Brian Zambrowicz, Robert R Henry. Diabetes Care 2015
97